{"id":96634,"date":"2019-07-29T15:18:27","date_gmt":"2019-07-29T12:18:27","guid":{"rendered":"https:\/\/www.enerjigazetesi.ist\/?p=96634"},"modified":"2019-07-29T15:51:16","modified_gmt":"2019-07-29T12:51:16","slug":"turkmen-nukleerdeki-ilerlemelerle-kanser-tarihe-karisabilir","status":"publish","type":"post","link":"https:\/\/www.enerjigazetesi.ist\/en\/turkmen-nukleerdeki-ilerlemelerle-kanser-tarihe-karisabilir\/","title":{"rendered":"(Turkish) T\u00fcrkmen: “N\u00fckleer’deki \u0130lerlemeler \u0130le Kanser Tarihe Kar\u0131\u015fabilir”"},"content":{"rendered":"

Sorry, this entry is only available in Turkish<\/a>. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.<\/p>

<\/p>\n

\u201cKANSER TEDAV\u0130S\u0130NDE N\u00dcKLEER REAKT\u00d6RLERE BA\u011eIMLIYIZ\u201d<\/strong><\/h1>\n

Mersin\u2019de Rosatom taraf\u0131ndan yap\u0131m\u0131 devam eden Akkuyu N\u00fckleer G\u00fc\u00e7 Santrali (NGS) ile n\u00fckleer santral sahibi \u00fclkelerin aras\u0131na kat\u0131lmaya haz\u0131rlan\u0131rken, santralin T\u00fcrkiye’de n\u00fckleer teknolojilerin geli\u015fmesine de katk\u0131 sa\u011flamas\u0131 ve d\u0131\u015fa ba\u011f\u0131ml\u0131l\u0131\u011f\u0131n\u0131 azaltmas\u0131 bekleniyor. Tar\u0131mdan hayvanc\u0131l\u0131\u011fa, t\u00fcketim \u00fcr\u00fcnlerinden g\u0131da g\u00fcvenli\u011fine, savunma sanayinden uzaya, havac\u0131l\u0131ktan elektrik \u00fcretimine kadar pek \u00e7ok alanda kullan\u0131lan n\u00fckleer teknolojinin \u00f6nemli alanlar\u0131ndan birini de sa\u011fl\u0131k sekt\u00f6r\u00fc olu\u015fturuyor. Kanser, kalp hastal\u0131klar\u0131, n\u00f6rolojik bozukluklar gibi \u00e7e\u015fitli hastal\u0131klar\u0131n tan\u0131 ve tedavisinde n\u00fckleer teknolojilerden faydalan\u0131rken, Hacettepe \u00dcniversitesi N\u00fckleer Enerji M\u00fchendisli\u011fi B\u00f6l\u00fcm\u00fc \u00d6\u011fretim Eleman\u0131 Dr. Mehmet T\u00fcrkmen, bilim d\u00fcnyas\u0131n\u0131n, n\u00fckleer teknoloji geli\u015ftik\u00e7e kanserin tarihe g\u00f6m\u00fclece\u011fine dair g\u00fc\u00e7l\u00fc kan\u0131tlar\u0131 oldu\u011funu s\u00f6yledi.<\/h1>\n

N\u00dcKLEER TES\u0130SLER \u00dcLKE \u0130\u00c7\u0130NDE OLMALI<\/strong><\/h2>\n

N\u00fckleer reakt\u00f6rlerin \u00fclke i\u00e7inde olmas\u0131n\u0131n \u00f6nemine dikkat \u00e7eken T\u00fcrkmen, “Ara\u015ft\u0131rma reakt\u00f6rleri, radyoterapinin yap\u0131ta\u015flar\u0131ndan olan radyoizotoplar\u0131n \u00fcretimi ve hastaya zaman\u0131nda ula\u015ft\u0131r\u0131lmas\u0131<\/p>\n

\"turkmen-nukleerdeki-ilerlemelerle-kanser-tarihe-karisabilir\"<\/p>\n

bak\u0131m\u0131ndan son derece \u00f6nemli. G\u00fcnde yakla\u015f\u0131k 140.000 n\u00fckleer t\u0131p uygulamas\u0131n\u0131n ger\u00e7ekle\u015ftirildi\u011fi d\u00fcnyada \u00fcretilen izotoplar\u0131n %90\u2019\u0131 hastal\u0131\u011f\u0131n te\u015fhisi i\u00e7in kullan\u0131lmakta olup \u00f6nemli tedarik\u00e7iler Fransa, Kanada, Rusya, ABD, Avrupa\u2019d\u0131r. Bu izotoplar do\u011fada bulunmad\u0131klar\u0131 i\u00e7in de en geli\u015fmi\u015f teknolojiye sahip tesislerde \u00fcretilmek zorunda. Dolay\u0131s\u0131yla, kanserle amans\u0131z m\u00fccadelemizi s\u00fcrd\u00fcrebilmemiz i\u00e7in n\u00fckleer teknolojiye g\u00fc\u00e7l\u00fc \u015fekilde ihtiya\u00e7 duyuyoruz. \u00dcstelik dakikalar mertebesine varabilen k\u0131sa yar\u0131 \u00f6m\u00fcrleri nedeniyle \u00fcretildikten \u00e7ok k\u0131sa s\u00fcre i\u00e7erisinde hastaya ula\u015ft\u0131r\u0131lmalar\u0131 gerekmekte. Bu y\u00fczden baz\u0131 n\u00fckleer tesisin \u00fclke i\u00e7erisinde kurulmas\u0131 zorunlulu\u011fu var. Kanser tedavisinde n\u00fckleer reakt\u00f6rlere ba\u011f\u0131ml\u0131 oldu\u011fumuzu s\u00f6yleyebilirim\u201d diye konu\u015ftu.<\/p>\n

KANSER\u0130N PANZEH\u0130R\u0130 RADYASYON<\/strong><\/h2>\n

Radyasyonun canl\u0131 h\u00fccreleri etkileyebilece\u011fini s\u00f6yleyen Dr. T\u00fcrkmen, \u201cAncak bu etki tedavi ama\u00e7l\u0131 da kullan\u0131labilir\u201d de\u011ferlendirmesinde bulundu. T\u00fcrkmen \u015funlar\u0131 s\u00f6yledi:<\/p>\n

\u201cRadyasyonun tedavi ama\u00e7l\u0131 kullan\u0131lmas\u0131, d\u0131\u015far\u0131dan bak\u0131ld\u0131\u011f\u0131nda bir hayli garip g\u00f6r\u00fcnebilir. T\u0131pk\u0131, zehirlenme vakalar\u0131nda panzehirin yine zehrin kendisi oldu\u011fu gibi, kanser tedavilerinde radyasyonun tam da bu etkisi kullan\u0131l\u0131r.\u201d<\/p>\n

RADYOTERAP\u0130DE BA\u015eARI \u015eANSI Y\u00dcKSEK<\/strong><\/h2>\n

Radyoterapide ba\u015far\u0131 oran\u0131n\u0131n, kanser tiplerine ba\u011fl\u0131 olarak y\u00fczde 100\u2019e kadar \u00e7\u0131kabildi\u011fini vurgulayan Dr. T\u00fcrkmen \u201cD\u00fcnyadaki kanser oranlar\u0131na bakt\u0131\u011f\u0131m\u0131zda Avusturalya en \u00fcst s\u0131rada yer al\u0131r. Onu, Yeni Zelanda, \u0130rlanda, Romanya ve ABD takip etmektedir. T\u00fcrkiye ise bu s\u0131ralamada ilk 50\u2019de bile de\u011fildir. D\u00fcnyada her 10 ki\u015fiden 2\u2019si kanserden \u00f6lmektedir. D\u00fcnya genelinde en s\u0131k g\u00f6r\u00fclen kanser t\u00fcrleri ise akci\u011fer, g\u00f6\u011f\u00fcs, kal\u0131n ba\u011f\u0131rsak, prostat, cilt ve midedir. Kanser t\u00fcrlerinin bu kadar \u00e7e\u015fitli oldu\u011fu yerde tedavinin de \u00e7abuk ve etkili olmas\u0131 gerekir. Bu konuda, ne\u015ftersiz bir tedavi y\u00f6ntemi olan radyoterapi, bug\u00fcn d\u00fcnya genelinde g\u00f6\u011f\u00fcs, tiroit, rahim ve prostat i\u00e7in hastalar\u0131n neredeyse tamam\u0131, testis ve hodgkin lenfoma i\u00e7in %95 ve melanom i\u00e7in %92 ba\u015far\u0131 oranlar\u0131 ile olduk\u00e7a iyi bir yerdedir. Tedavi i\u00e7in gama \u0131\u015f\u0131nlar\u0131, elektronlar, protonlar, n\u00f6tronlar gibi atom alt\u0131 par\u00e7ac\u0131klar\u0131n\u0131n neredeyse tamam\u0131 kullan\u0131l\u0131yor. Bu par\u00e7ac\u0131klar\u0131 \u00fcretmek i\u00e7in en geli\u015fmi\u015f ara\u015ft\u0131rma reakt\u00f6rlerine ve h\u0131zland\u0131r\u0131c\u0131lara ihtiya\u00e7 var. ABD ve Avrupa\u2019da bir\u00e7ok hastanede ara\u015ft\u0131rma ve e\u011fitim reakt\u00f6rleri hastane b\u00fcnyelerinde yer al\u0131yor. Hastalar, reakt\u00f6r i\u00e7erisinde tedavi ediliyor. Bizim \u00fclkemizdeki 2 ara\u015ft\u0131rma reakt\u00f6r\u00fc ise tedavi ama\u00e7l\u0131 kullan\u0131lm\u0131yor. Bunlar\u0131n yerine 100\u2019\u00fcn \u00fczerindeki radyoterapi merkezinde daha kompakt ve nispeten daha ucuz olan x-ray cihazlar\u0131 ve h\u0131zland\u0131r\u0131c\u0131lardan yararlan\u0131l\u0131yor\u201d \u015feklinde konu\u015ftu.<\/p>\n

N\u00dcKLEER TES\u0130S\u0130N \u00dcLKE \u0130\u00c7\u0130NDE KURULMASI ZORUNLU<\/strong><\/h2>\n

\u201cG\u00fcn\u00fcm\u00fczde n\u00fckleer teknoloji seviyesi ile \u00fcretilemeyecek neredeyse hi\u00e7bir radyoizotop yoktur\u201d diyen Dr. T\u00fcrkmen, n\u00fckleer t\u0131p uygulamalar\u0131ndaki d\u0131\u015fa ba\u011f\u0131ml\u0131l\u0131k sorunun \u00e7\u00f6z\u00fclmesi gerekti\u011fine dikkat \u00e7ekti. T\u00fcrkmen \u015f\u00f6yle devam etti:<\/span><\/p>\n

\u201cN\u00fckleer reakt\u00f6rlerde kullan\u0131lan g\u00f6r\u00fcnt\u00fcleme cihazlar\u0131, detekt\u00f6rler, dozimetreler, z\u0131rhlama malzemeleri gibi teknolojik \u00fcr\u00fcnlerin tamam\u0131 n\u00fckleer t\u0131p alan\u0131nda da kullan\u0131l\u0131yor. Dolay\u0131s\u0131yla, bir alandaki geli\u015fme di\u011fer alan\u0131n da geli\u015fmesine yard\u0131mc\u0131 olacakt\u0131r. I\u015f\u0131n tedavilerinde kullan\u0131lan do\u011frusal h\u0131zland\u0131r\u0131c\u0131 cihazlar\u0131n, radyasyon dozu \u00f6l\u00e7en dozimetrelerin ve yine radyasyon \u00f6l\u00e7\u00fcm\u00fcnde kullan\u0131lan detekt\u00f6rlerin tamam\u0131 yurtd\u0131\u015f\u0131ndan sipari\u015f ediliyor. Baz\u0131 izotoplar ara\u015ft\u0131rma reakt\u00f6rleri olmadan yeterli miktarda \u00fcretilemiyor; h\u0131zland\u0131r\u0131c\u0131larda az miktarda fakat pahal\u0131ya \u00fcretiliyor. Radyoizotoplar, \u00e7ok k\u0131sa s\u00fcre i\u00e7erisinde hastaya ula\u015ft\u0131r\u0131lmak zorunda. \u00d6rne\u011fin, karaci\u011fer kanseri tedavisinde kullan\u0131lan itriyum-90 izotopunun radyoaktivite seviyesi 64 saat i\u00e7inde yar\u0131ya d\u00fc\u015f\u00fcyor. \u00dclkemizde, geni\u015f \u00e7apl\u0131 n\u00fckleer uygulamalar\u0131n ger\u00e7ekle\u015ftirilebilece\u011fi bir ara\u015ft\u0131rma ve e\u011fitim reakt\u00f6r\u00fcne ihtiya\u00e7 var. N\u00fckleer tesisin \u00fclke i\u00e7erisinde kurulmas\u0131 zorunlu. D\u00fcnyada her y\u0131l 50 milyona yak\u0131n n\u00fckleer t\u0131p uygulamas\u0131 ger\u00e7ekle\u015ftiriliyor, radyoizotop ihtiyac\u0131 y\u0131ll\u0131k y\u00fczde 5 oran\u0131nda art\u0131yor. N\u00fckleer t\u0131p radyoizotop market b\u00fcy\u00fckl\u00fc\u011f\u00fc 11 milyar dolara ula\u015ft\u0131. \u0130zotop \u00fcretim teknolojilerinde \u00f6nemli bir oyuncu olmak i\u00e7in \u00fclkemizde gerekli giri\u015fimlerin acilen ba\u015flat\u0131lmas\u0131 gerekiyor.\u201d<\/p>\n

YEN\u0130 TEDAV\u0130 Y\u00d6NTEMLER\u0130 \u0130\u00c7\u0130N N\u00dcKLEER TEKNOLOJ\u0130 \u015eART<\/strong><\/h2>\n

N\u00fckleer teknolojilerin kanserle m\u00fccadelede \u00e7ok \u00f6nemli geli\u015fmelere gebe oldu\u011funa dikkat \u00e7eken T\u00fcrkmen \u201cI\u015f\u0131n tedavisi yap\u0131lacak b\u00f6lgede kanserli h\u00fccrelerin yan\u0131 s\u0131ra bir miktar sa\u011fl\u0131kl\u0131 h\u00fccrede ka\u00e7\u0131n\u0131lmaz olarak \u0131\u015f\u0131nlan\u0131r. Do\u011frudan ve sadece kanserli h\u00fccreleri yok etme fikrine dayanan \u2018Bor N\u00f6tron Yakalama Tedavisi\u2019nin \u00f6n\u00fcm\u00fczdeki birka\u00e7 on y\u0131l i\u00e7inde bu soruna \u00e7are olmas\u0131n\u0131 bekliyoruz. Ayr\u0131ca, ki\u015fiselle\u015ftirilmi\u015f t\u0131p uygulamalar\u0131 ile kanserin te\u015fhisi, v\u00fccut i\u00e7indeki konumu, da\u011f\u0131l\u0131m\u0131 ve b\u00fcy\u00fckl\u00fc\u011f\u00fc kesin olarak belirlenecek; ki\u015fiye \u00f6zel tedavi plan\u0131 haz\u0131rlanabilecek ve hasta daha az radyasyona maruz kalarak h\u0131zl\u0131ca tedavi edilebilecek. Tedavi maliyetleri azalacak; ba\u015far\u0131 oranlar\u0131 ciddi miktarda artacak. N\u00fckleer teknoloji geli\u015ftik\u00e7e kanserin bir hastal\u0131k olmaktan \u00e7\u0131kaca\u011f\u0131na dair g\u00fc\u00e7l\u00fc kan\u0131tlar\u0131m\u0131z var.<\/strong> 21\u2019inci y\u00fczy\u0131lda hayat\u0131m\u0131z\u0131 \u015fekillendiren, kolayla\u015ft\u0131ran, ya\u015fam konforumuzu art\u0131ran her ne varsa n\u00fckleer bilim ve teknolojideki geli\u015fmeler sayesindedir\u201d diye konu\u015ftu.<\/p>\n

ULUSAL PROTOKOL GEREK\u0130YOR<\/strong><\/h2>\n

Dr. T\u00fcrkmen de, kanser tedavisinde ulusal protokol ihtiyac\u0131na dikkat \u00e7ekti. T\u00fcrkmen, \u201cAyr\u0131ca, kanser tedavilerinde \u00fclkemizin yabanc\u0131 hastalara bir cazibe merkezi olmas\u0131 i\u00e7in geni\u015f \u00e7apl\u0131 n\u00fckleer uygulamalar\u0131n ger\u00e7ekle\u015ftirilebilece\u011fi bir ara\u015ft\u0131rma ve e\u011fitim reakt\u00f6r\u00fcne ihtiya\u00e7 duyulmaktad\u0131r. Son olarak, \u015fu anda kullan\u0131lan tedavi protokolleri yurtd\u0131\u015f\u0131 kaynakl\u0131d\u0131r. Ulusal protokollerin olu\u015fturulmas\u0131 radyoterapi alandaki eksikliklerimizi h\u0131zl\u0131ca kapatmak i\u00e7in \u00f6nemlidir\u201d ifadelerini kulland\u0131.<\/p>\n

SADECE KANSER TEDAV\u0130S\u0130NDE DE\u011e\u0130L HER ALANDA<\/strong><\/h2>\n

N\u00fckleer teknolojinin sadece kanserle m\u00fccadelede de\u011fil, her alanda hayat\u0131 \u00e7ok kolayla\u015ft\u0131rd\u0131\u011f\u0131n\u0131 kaydeden T\u00fcrkmen, \u201cN\u00fckleer g\u00f6r\u00fcnt\u00fcleme teknikleri bug\u00fcn, di\u015f filmi \u00e7ekiminden AVM\u2019lerde g\u00fcvenlik ama\u00e7l\u0131 kullan\u0131m\u0131na kadar bir\u00e7ok alanda de\u011ferlendiriliyor. G\u00f6r\u00fcnt\u00fcleme teknikleri sayesinde u\u00e7ak, gemi gibi ta\u015f\u0131tlardaki sorunlar \u00f6nceden fark edilmekte olas\u0131 kazalar\u0131n \u00f6n\u00fcne ge\u00e7ilmektedir\u201d dedi.<\/p>\n

SA\u011eLIKTA YERL\u0130LE\u015eMEYE KATKI <\/strong><\/h2>\n

T\u00fcrkiye’de n\u00fckleer teknolojinin geli\u015fmesinin sa\u011fl\u0131kta yerlile\u015ftirilmeye katk\u0131 sa\u011flayaca\u011f\u0131 \u00f6ng\u00f6r\u00fcl\u00fcyor. \u00dclkenin ilk n\u00fckleer enerji santrali Akkuyu NGS’nin de hem teknoloji geli\u015fimine hem de insan kayna\u011f\u0131n\u0131n geli\u015fimine katk\u0131 sa\u011flayacak \u00f6nemli bir proje oldu\u011funa dikkat \u00e7ekiliyor. Santrali yapan Devlet Atom Enerjisi \u015eirketi Rosatom’un ana faaliyetlerinden birini de n\u00fckleer t\u0131p olu\u015fturuyor. Bilhassa, Rosatom Devlet Kurulu\u015fu’nun i\u015ftiraki \u015firketlerinden Rusatom Healthcare, Rosatom \u00e7at\u0131s\u0131 alt\u0131nda bu alanda faaliyet g\u00f6stermektedir.”<\/p>","protected":false},"excerpt":{"rendered":"

Sorry, this entry is only available in Turkish. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. \u201cKANSER TEDAV\u0130S\u0130NDE N\u00dcKLEER REAKT\u00d6RLERE BA\u011eIMLIYIZ\u201d Mersin\u2019de Rosatom taraf\u0131ndan yap\u0131m\u0131 devam eden Akkuyu N\u00fckleer G\u00fc\u00e7 Santrali (NGS) ile n\u00fckleer santral sahibi \u00fclkelerin aras\u0131na […]<\/p>\n","protected":false},"author":1,"featured_media":96637,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[51,53,43],"tags":[3019,48024,54507,54502,54503,52259,15243,54499,54505,1301,23134,14771,36444,22542,54497,54496,25480,34931,34930,14895,54506,54504,2322,54500,2587,45686,54498,54508,54501],"views":509,"_links":{"self":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts\/96634"}],"collection":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/comments?post=96634"}],"version-history":[{"count":0,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts\/96634\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/media\/96637"}],"wp:attachment":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/media?parent=96634"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/categories?post=96634"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/tags?post=96634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}